| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |